We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warns of Risk of Death With Multiple Myeloma Drug Pepaxto
FDA Warns of Risk of Death With Multiple Myeloma Drug Pepaxto
The FDA has issued a rare warning about the multiple myeloma drug Pepaxto (melphalan flufenamide), saying a recent confirmatory trial showed an increased risk of death.